<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03877042</url>
  </required_header>
  <id_info>
    <org_study_id>XJ2018004</org_study_id>
    <nct_id>NCT03877042</nct_id>
  </id_info>
  <brief_title>The Efficacy of Using CR and PS Prosthesis in Total Knee Replacement</brief_title>
  <official_title>The Efficacy of Using CR and PS Prosthesis in Total Knee Replacement: a Randomized, Double-blind, Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Xijing Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Xijing Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigators will investigate the efficacy of using CR and PS implants in TKA. The
      investigators will conduct TKA with different implants simultaneously on one patient to
      compare the post-operation efficacy of both implants.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      A randomized, single-center, single group study comparing the efficacy and safety of using CR
      and PS implants in TKA. The investigators will conduct TKA with different implants
      simultaneously on one patient to compare the post-operation efficacy of both implants.
      Subjects will be monitored through postoperative follow-up to understand the bilateral knee
      condition.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">December 1, 2018</start_date>
  <completion_date type="Anticipated">December 2021</completion_date>
  <primary_completion_date type="Anticipated">December 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>HSS score changes after TKA</measure>
    <time_frame>1,3,6,12 months after TKA</time_frame>
    <description>Summed Hospital for special surgery (HSS) score with a maximum score of 100. Higher values represent a better outcome.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>KSS score changes after TKA</measure>
    <time_frame>1,3,6,12 months after TKA</time_frame>
    <description>Summed Knee Society Score (KSS) score with a maximum score of 100. Higher values represent a better outcome.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>X-ray evaluation changes after TKA</measure>
    <time_frame>1,3,6,12 months after TKA</time_frame>
    <description>Evaluation of postoperative X-ray results for lower limb line, prosthesis location and other conditions</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Muscle strength measurement changes after TKA</measure>
    <time_frame>1,3,6,12 months after TKA</time_frame>
    <description>Strength measurement of related muscles according to Lovett muscle strength grading standard.</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Total Knee Arthroplasty</condition>
  <arm_group>
    <arm_group_label>Experimental</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients with end-stage knee disease need Total Knee Arthroplasty in both knees.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Cruciate-retaining (CR) prostheses</intervention_name>
    <description>One leg is conducted TKA with Cruciate-retaining (CR) prostheses.</description>
    <arm_group_label>Experimental</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Posterior-stabilized (PS) prostheses</intervention_name>
    <description>One leg is conducted TKA with Posterior-stabilized (PS) prostheses.</description>
    <arm_group_label>Experimental</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Adult patients who plan to undergo primary total knee arthroplasty on bilateral knee
             joint with a diagnosis of osteoarthritis or rheumatoid arthritis, etc.;

        Exclusion Criteria:

          -  Those who do not meet the inclusion criteria;

          -  Neuromuscular dysfunction;

          -  Diseases affecting postoperative efficacy evaluation
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Qingsheng Zhu, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Fourth Military Medical University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Zhao Yan, MD</last_name>
    <phone>+86-29-84775280</phone>
    <email>yanzhaoii@163.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Xijing Hospital</name>
      <address>
        <city>Xi'an</city>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Chongfei Yang, M.D.</last_name>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>March 2019</verification_date>
  <study_first_submitted>March 6, 2019</study_first_submitted>
  <study_first_submitted_qc>March 13, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">March 15, 2019</study_first_posted>
  <last_update_submitted>March 13, 2019</last_update_submitted>
  <last_update_submitted_qc>March 13, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">March 15, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Xijing Hospital</investigator_affiliation>
    <investigator_full_name>Yanzhao</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>Total Knee Arthroplasty</keyword>
  <keyword>CR</keyword>
  <keyword>PS</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

